Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R O Snyder

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Experimental Neurology|March 1, 1997
Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's diseaseK S Bankiewicz, S E Leff, D Nagy, et al.
The Journal of Gene Medicine|March 30, 2000
Selective uptake and sustained expression of AAV vectors following subcutaneous deliveryB A Donahue, J G McArthur, S K Spratt, et al.
Nature Biotechnology|August 14, 1998
Regulation of gene expression in vivo following transduction by two separate rAAV vectorsK G Rendahl, S E Leff, G R Otten, et al.
Nature Genetics|July 1, 1997
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsR O Snyder, C H Miao, G A Patijn, et al.
Nature Medicine|January 12, 1999
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsR O Snyder, C Miao, L Meuse, et al.
Gene Therapy|January 23, 2004
Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunityY C Zhang, M Powers, C Wasserfall, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Experimental Neurology|March 1, 1997
Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's diseaseK S Bankiewicz, S E Leff, D Nagy, et al.
The Journal of Gene Medicine|March 30, 2000
Selective uptake and sustained expression of AAV vectors following subcutaneous deliveryB A Donahue, J G McArthur, S K Spratt, et al.
Nature Biotechnology|August 14, 1998
Regulation of gene expression in vivo following transduction by two separate rAAV vectorsK G Rendahl, S E Leff, G R Otten, et al.
Nature Genetics|July 1, 1997
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsR O Snyder, C H Miao, G A Patijn, et al.
Nature Medicine|January 12, 1999
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsR O Snyder, C Miao, L Meuse, et al.
Gene Therapy|January 23, 2004
Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunityY C Zhang, M Powers, C Wasserfall, et al.
Pageof 3